Search research articles
Contact Us
Filters
Showing results (1441-1450 of 1,472) with videos related to
Page
of 148
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Gastroenterology
|
October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Annals of Hepatology
|
April 7, 2016
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials
Donald M Jensen, Tarik Asselah, Douglas Dieterich, et al.
Ecology
|
April 28, 2025
When can we detect lianas from space? Toward a mechanistic understanding of liana-infested forest optics
Marco D Visser, Matteo Detto, Félicien Meunier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 2007
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases
Amy D Brideau-Andersen, Xiaojian Huang, Siu-Chi Chang Sun, et al.
BMC Medical Informatics and Decision Making
|
October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisions
Alvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
Alimentary Pharmacology & Therapeutics
|
September 16, 2016
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B
P Marcellin, S H Ahn, W-L Chuang, et al.
The Lancet. Gastroenterology & Hepatology
|
August 14, 2017
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials
Edward J Gane, Stephen Pianko, Stuart K Roberts, et al.
Microbiome
|
May 14, 2024
Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity
Chee Kin Then, Salome Paillas, Aliu Moomin, et al.
Nature Communications
|
August 27, 2025
The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cells
Róbert Zach, Michael Annis, Sandra M Martin-Guerrero, et al.
Page
of 148
Search research articles
Search
Showing results (1441-1450 of 1,472) with videos related to
Sort By:
Page
of 148
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2018
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B Y Ma, Wan-Teck Lim, Boon-Cher Goh, et al.
Gastroenterology
|
October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Annals of Hepatology
|
April 7, 2016
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials
Donald M Jensen, Tarik Asselah, Douglas Dieterich, et al.
Ecology
|
April 28, 2025
When can we detect lianas from space? Toward a mechanistic understanding of liana-infested forest optics
Marco D Visser, Matteo Detto, Félicien Meunier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 2007
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases
Amy D Brideau-Andersen, Xiaojian Huang, Siu-Chi Chang Sun, et al.
BMC Medical Informatics and Decision Making
|
October 13, 2021
An informatics consult approach for generating clinical evidence for treatment decisions
Alvina G Lai, Wai Hoong Chang, Constantinos A Parisinos, et al.
Alimentary Pharmacology & Therapeutics
|
September 16, 2016
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B
P Marcellin, S H Ahn, W-L Chuang, et al.
The Lancet. Gastroenterology & Hepatology
|
August 14, 2017
Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials
Edward J Gane, Stephen Pianko, Stuart K Roberts, et al.
Microbiome
|
May 14, 2024
Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity
Chee Kin Then, Salome Paillas, Aliu Moomin, et al.
Nature Communications
|
August 27, 2025
The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cells
Róbert Zach, Michael Annis, Sandra M Martin-Guerrero, et al.
Page
of 148